Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

Conditions:   Insulin;   Exercise Interventions:   Drug: Placebo into the intranasal mucosa;   Drug: 20 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 40 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 60 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 80 IU NovoLog Insulin aspart into the intr anasal mucosa;   Drug: 100 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 120 IU NovoLog Insulin aspart into the intranasal mucosa Sponsor:   Michigan State University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials